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ABSTRACT 
Systematic reviews (SR) are an evidence synthesis approach that provides robust and transparent answers to 
clearly formulated questions. Originally developed for use in clinical practice, SRs have wider applicability, 
including food and feed safety risk assessment. EFSA has implemented the use of SRs, and this document 
contributes to the further development of this in-house capacity. Since the publication of the document 
“Application of Systematic Review Methodology to Food and Feed Safety Assessments to Support Decision 
Making”, which mainly focuses on interventions and exposures (PECO/PICO), little has changed in this arena. 
Fast increasing fields of application include chemical and environmental risk assessment, and analysing 
environmental management interventions. Considering time constraints at EFSA, the use of SRs should be 
pursued thoughtfully. Important are the use of explicit systematic methods aimed at minimising bias and 
maximising transparency in order to produce the most reliable findings that can be used to inform decision 
making. Participants of the training courses indicated SRs should be a priority for controversial topics (which 
might be subject to greater scrutiny by external parties, including the public, and thereby would benefit from 
maximum transparency) or topics for which there was disagreement amongst experts. Some areas addressed by 
EFSA have considerable potential impact, for example related to public health or animal trade, and these topics 
could be prioritised for SR. Under severe time constraints, a full SR may not be possible, but a rapid review can 
be considered. However rapid reviews are not a substitute for systematic reviews. Adoption of rapid reviews 
exchanges one set of concerns (time and resources contracts) for another (lack of robustness and 
comprehensiveness). In the view of the Consortium, the continuation of training opportunities is important. 
Appropriate commissioning of SR expertise is an important step in establishing the role of the methodology in 
EFSA risk assessments. 
 
© Copyright European Food Safety Authority 
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BACKGROUND AS PROVIDED BY EFSA 
In human health research, it is widely acknowledged that systematic reviews (SR) are the best 
evidence synthesis practices to provide robust and unbiased answers to clearly formulated clinical 
questions. Formal systematic reviews have not commonly been used in food and feed safety risk 
assessment (RA) and the systematic review methods existing in human health research may not be 
directly applicable in this field. 
The use of systematic reviews to food and feed safety risk assessment has recently been analysed by 
The European Food Safety Authority (EFSA) in an EFSA Guidance (EFSA, 2010
2
), which provides a 
framework for identifying the different types of question suitable for systematic review within broad 
food and feed safety risk assessments; some suggestions on how to prioritise questions for formal 
systematic reviews; and advice and examples for the conduct of the systematic review process. The 
Guidance was presented and discussed in a workshop
3
 attended by fifty participants, comprising EFSA 
Panel members and scientific staff. 
During the open sessions of the workshop, it was highlighted how most of the principles of systematic 
review (methodological rigour, transparency, and reproducibility) are already in use in EFSA; 
however, the standardised-structure of the systematic review process is not always used, and the 
formal implementation of the SR method may provide an added value to EFSA food and feed safety 
assessments. 
The large majority of the participants acknowledged that such types of workshop are useful for the 
work of EFSA and that other experts and EFSA staff would benefit by attending such workshops. The 
need for tailored workshops focussed on the integration of SR into food and feed safety RA and for 
practical sessions focussed on EFSA areas of analysis was also highlighted. 
In order to implement systematic reviews in EFSA scientific outputs workflow, it is necessary to 
develop in-house capacity to apply systematic reviews to food and feed safety risk assessment and to 
further analyse the SR method in view of the specific requirements of this field, such as e.g. 
developing a well-structured framework for prioritising questions for formal systematic reviews or for 
adapting the SR method in case of e.g. limited timeframes. 
In view of the above EFSA launched a call for tender aiming to support systematic review 
implementation in EFSA scientific outputs workflow. The specific objectives of the procurement 
procedure were: (i) to support EFSA in developing in-house capacity to apply systematic reviews to 
food and feed safety risk assessment, by providing specific trainings; (ii) to analyse the SR method in 
view of the specific requirements of food and feed safety risk assessment in support of decision 
making.  
TERMS OF REFERENCE AS PROVIDED BY EFSA 
The call for tenders required the awarded tenderer to provide EFSA with the following deliverables: 
 First deliverable: Three EFSA-tailored trainings on the use of systematic reviews in food and 
feed safety risk assessment. 
                                                     
2
 EFSA (European Food Safety Authority), 2010. Application of systematic review methodology to food and 
feed safety assessments to support decision making. The EFSA Journal (2010), 8(5):1637, pp. 1-90. Available at: 
http://www.efsa.europa.eu/en/scdocs/scdoc/1637.htm 
3
 The workshop was held in EFSA in February 2010. 
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 Second deliverable: a Report on the use of SR in food and feed safety risk assessment, which 
may serve as a basis for updating the EFSA Guidance on the Application of systematic review 
methodology to food and feed safety assessments to support decision making. The Report 
shall address, among other topics, a well-defined framework for prioritising questions for 
systematic reviews in the context of food and feed safety RA and provide suggestions on how 
to adapt the SR method in case of limited resources (e.g. short deadlines). Resource impact 
shall also be assessed. The feedback from the participants to the trainings shall be considered 
when producing such Report. 
This contract was awarded by EFSA to: 
Contractor: The Consortium. 
Contract title: Implementation of systematic reviews in EFSA scientific outputs workflow. 
Contract number: CFT/EFSA/AMU/2010/01. 
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INTRODUCTION AND OBJECTIVES 
Systematic reviews are widely acknowledged as an evidence synthesis approach that provides robust 
and transparent answers to clearly formulated clinical questions. However formal systematic reviews 
have not commonly been used in food and feed safety risk assessment (RA) and the systematic review 
methods existing in human health research may not be directly applicable in this field. EFSA, as a 
leading agency worldwide that provides policy support for all aspects of food and feed safety, has 
implemented the use of systematic reviews. As part of that implementation process, EFSA awarded 
tenderer to our Consortium to provide two deliverables.  
The objectives of the tender were: 
 to support EFSA in developing in-house capacity to apply systematic reviews to food and feed 
safety risk assessment, by providing specific trainings;  
 to analyse the SR method in view of the specific requirements of food and feed safety risk 
assessment in support of decision making.  
To achieve these objectives, the Consortium was established with two aims and two corresponding 
deliverables. The first aim was to increase understanding of systematic review process and therefore 
increase the capacity of EFSA to conduct systematic reviews. The second aim was to provide a report 
to EFSA about the unique aspects of systematic reviews that relate to feed and food safety. The 
approach to delivering the first aim was to hold three training sessions in Parma in 2011-2012 that 
introduced the systematic review methodology to EFSA staff and panel members. This report is the 
deliverable for the 2
nd
 objective, i.e. an analysis, in the form of a report, which may serve as a basis for 
updating the EFSA Guidance on the application of systematic review methodology to food and feed 
safety assessments to support decision making.  
MATERIALS AND METHODS 
Approach to developing the report. 
In developing this report, designed to meet the 2
nd
 objective of the tender, the following approach was 
used. The call for tender defined three components to include in the report:  
1) A well-defined framework for prioritising questions for systematic reviews in the context of 
food and feed safety RA. 
2) Suggestions on how to adapt the SR method in case of limited resources (e.g. short deadlines).  
3) Resource impact shall also be assessed. 
Each section was then addressed separately.  
For the issue of prioritisation of review questions, the Consortium drew upon numerous resources. 
a. The experiences of the Consortium members were used. The Consortium members represent a 
great of deal of available experience in the systematic reviews relevant to the food and feed 
safety domain. Therefore in meetings of the Consortium, phone and email conversations and 
report drafts, Consortium members provided their experiences in prioritisation. 
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b. Further, published literature available on prioritisation of systematic reviews was sought. The 
search for literature was conducted in PubMed using the terms “prioritization AND 
(systematic reviews OR Health technology assessment). Relevant publications were identified, 
and the PubMed related citations feature was used to identify other studies. A convenience 
search of Google was used using a variety of terms such as “systematic reviews”, 
“prioritization” to identify reports. The reference lists of publications that appeared relevant to 
the topic of prioritisation were also searched. Some Consortium members also suggested 
publications. Findings from these papers were considered in the discussion about 
prioritisation. 
c. Further, during the training sessions, EFSA panel members and staff members who were 
present at the final day discussion were directly asked to provide their opinions of 
prioritisation of systematic reviews for EFSA. This information was gathered in each of the 3 
training sessions. In each group one of the training team recorded this information. At the 
conclusion of the meeting, one of the Consortium members compiled this information. This 
feedback was also considered in the discussion about prioritisation. 
d. Questions related to prioritisation were included in the questionnaire administered at the end 
of each training session. When relevant to deliverable 2 (rather than deliverable 1 as defined 
by the EFSA terms of reference), these responses were incorporated into the review. Three 
training workshops were held in 2011-2012 with participants including EFSA staff and panel 
members. During the training workshops, time was allocated to discuss the perceived role of 
systematic reviews in EFSA’s work programmes, as well as facilitators and barriers to their 
use. The time was allocated both within the content specific working groups and, during the 
final morning of each workshop, with all workshop participants. This information was 
collected by the Consortium members, compiled and discussed to create this summary. 
Responses from post-training questionnaires, completed by participants following each of the 
three training workshops, were compiled by EFSA (SAS) staff and made available to the 
Consortium. 
e. EFSA staff also provided feedback and comments to the report and offered opinions about the 
approach to prioritisation proposed by the Consortium. This information often related to 
aspects of EFSA practice or relevance of approaches to EFSA process. 
For the 2
nd
 component of the report, i.e. suggestions on how to modify the systematic review process 
in the case of limited resources, the same approach was used. However, in this circumstance we 
concentrated on literature about rapid reviews that are conducted in human medicine. This search was 
not a formal systematic literature search. Instead, members of the Consortium provided publications 
they were aware of that related to rapid reviews. These publications were used as the basis for 
identifying other information, through PUBMED related references and identifying relevant 
publications in the bibliography. Again, our multidisciplinary Consortium members brought their own 
experiences with conducting reviews in situations with limited resources. Discussion items from the 
training sessions raised by EFSA staff and panel members when relevant were considered by the 
Consortium members in reaching conclusions for the report. Finally, again EFSA staff provided 
feedback and comments to the report and offered opinions about rapid review proposed by the 
Consortium. This information often related to aspects of EFSA practice or relevance of approaches to 
EFSA process. 
For the 3
rd
 component of the report the Consortium addressed the resource implications of systematic 
reviews. The approach to this was to draw on the experiences of the Consortium members conducting 
reviews, and comments from EFSA staff made formally and informally during training sessions. 
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1. An overview of the current use of systematic reviews in food and feed safety 
EFSA published EFSA Guidance “Application of Systematic Review Methodology to Food and Feed 
Safety Assessments to Support Decision Making”1 (hereafter referred to as “the Guidance”) in 2010. 
Since the Guidance was published little has changed in the fundamental methods used to conduct 
systematic reviews. The Guidance focuses mainly on interventions and exposure questions 
(PECO/PICO), reflecting the fact that the methods for conducting systematic reviews are most 
developed, even in human medicine, for interventions, and little has changed in this arena. 
For reviews of diagnostic test accuracy studies (PIT questions), the work of the Cochrane 
Collaboration in developing guidance for Reviews of Diagnostic Test Accuracy (DTA questions) is 
progressing slowly. No new material has been published on the Cochrane DTA working group website 
since 2009
4
. Beyond the Cochrane Collaboration, a recently published issue of the Journal of General 
Internal Medicine has focused entirely on reviews of medical tests (Hartmann et al., 2012; Jonas et al., 
2012; Matchar, 2012; Rector et al., 2012; Relevo, 2012; Samson and Schoelles, 2012; Santaguida et 
al., 2012; Segal, 2012; Singh et al., 2012; Trikalinos and Balion, 2012; Trikalinos et al., 2012a; 
Trikalinos et al., 2012b). This work was funded by the US - based Agency for Healthcare Research 
and Quality (AHRQ). The suitability of translating these methods for conducting diagnostic test 
accuracy reviews to topics in food and feed safety has not been assessed by the project Consortium, 
because of its recent publication. However, if EFSA staff or experts are required to conduct a review 
of DTA, this special issue appears to be the most comprehensive resource currently available.  
For reviews of population characteristics (PO questions) and reviews of disease causation (PECO 
questions) (Khan et al., 2012), no major changes in methods have been published, although a few new 
summary papers have been published that may be of interest (Khan et al., 2012). 
Although there have been no major changes in the systematic review methods that are particularly 
relevant to the EFSA domains
5
, this is likely to change in the next 3-5 years. The number of topics in 
EFSA’s domains that are starting to employ systematic review methods is growing and within each 
area the number of published systematic reviews is also growing. It is expected that this growth will 
result in increased experience and understanding of when and how systematic review approaches used 
in human medicine can be directly translated to food and feed safety reviews.  
The EFSA domain with the largest number of published systematic reviews continues to be human 
nutrition where numerous reviews of the efficacy and safety of nutrient supplements are readily 
available (Abad and Safdar, 2009; Braegger et al., 2011; Brenner et al., 2009; Chmielewska and 
Szajewska, 2010; Deshpande et al., 2007; Gotteland et al., 2006; Hempel et al., 2012; Holte et al., 
2012; Hoveyda et al., 2009; Jonkers et al., 2012; Levri et al., 2005; Mihatsch et al., 2012; Moayyedi et 
al., 2010; Monachese et al., 2011; Nichols, 2007; Salari et al., 2012). 
Another area where the number of published systematic reviews is increasing is biological hazards 
associated with food proteins (Bucher et al., 2012a; Bucher et al., 2012b; Domingues et al., 2012a, b; 
Ilic et al., 2012; Irwin et al., 2011; Matthews et al., 2012). 
Similarly, several reviews of animal health have been published (Anderson et al., 2009; Burns and 
O'Connor, 2008; Duffield et al., 2012; Duffield et al., 2008a, b, c; Lean et al., 2009; O'Connor et al., 
                                                     
4
 http://srdta.cochrane.org 
5
 Chemical risk assessment, microbial risk assessment, environmental risk assessment, human nutrition, animal 
nutrition, animal health and welfare risk assessment, animal cloning, plant health risk assessment. 
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2011; O'Connor et al., 2010b; Wellman and O'Connor, 2007) although the use of the systematic 
review method in animal welfare and behaviour remains rare. 
One important area where the number of systematic reviews has increased is animal-based biomedical 
research (Macleod and Sandercock, 2005; Macleod and van der Worp, 2010; Macleod et al., 2004; 
O'Collins et al., 2006; Perel et al., 2007; Sena et al., 2010; van der Worp et al., 2010). This increase is 
relevant to environmental and chemical risk assessment, which frequently uses animal-based studies 
as the only evidence base (Heard et al., 2011; van der Zande et al., 2011). 
Additionally, an increasing number of reviews in environmental management are being conducted 
according to the guidelines of the Collaboration for Environmental Evidence 
(www.environmentalevidence.org), including some topics relevant to EFSA’s mission. 
The increasing number of systematic reviews in EFSA’s domains of interest means that, increasingly, 
EFSA staff and experts may need to explore whether a suitable and relevant systematic review already 
exists on a topic prior to commissioning or conducting such a review. The second implication of the 
growth in systematic reviews in food and feed safety is that EFSA should continue to determine which 
standards must be met for a previously conducted systematic review to be considered adequate. This is 
a critical issue, as clearly no two review panels would be likely to compose exactly the same PICO, 
PECO, PIT or PO question or establish the same eligibility criteria. However, there are considerable 
savings in time and resources if available reviews can be used to inform risk assessment. 
1.1. Assessing the need for new systematic reviews 
The Consortium recommends EFSA consider establishing a process for determining the need for new 
systematic reviews, when systematic reviews on the same topic(s) are available. These standards are 
likely to encompass a range of elements related to already existing reviews: relevance to the mandate; 
and rigour and transparency of the methods used. For some elements, existing standards such as 
PRISMA (Liberati et al., 2009; Moher et al., 2009), which describes the minimal elements needed for 
reporting systematic reviews, or the AMSTAR (Faggion et al., 2011; Shea et al., 2007a; Shea et al., 
2007b; Shea et al., 2009), which is used for appraising the methodological quality of systematic 
reviews, may be helpful. However, other elements of the standards may need to be developed 
specifically for EFSA. 
For instance, for assessing the quality of existing systematic reviews it is unlikely that AMSTAR 
standards or other existing appraisal tools will be able to be adopted by EFSA without any 
modification because for the assessment of “quality” topic specific information is nearly always 
necessary. An example to illustrate this issue would be a hypothetical example of a review of E coli 
0.157 prevalence conducted in the USA prior to late 1990’s. If such a review existed, it may be 
implemented in line with the standards of the AMSTAR or other existing quality appraisal tools for 
SRs, but would still not be applicable by EFSA because of the change in diagnostic tests since the late 
1990’s. 
Experts with topic specific knowledge will need to be consulted to assess the quality and applicability 
of prior reviews. Obviously, if the reviews are not reported comprehensively it will be very difficult to 
assess quality. Therefore, it should be possible for EFSA staff to assess the comprehensiveness of 
reporting using PRISMA, and then for those reviews that do meet reporting standards experts could be 
consulted about the quality of topic specific information. The topic specific nature of quality 
assessment is the reason why although internationally accepted standards for reporting guidelines are 
available for many study designs, the availability of quality assessment tools tend to be limited and 
topic specific (Wong et al., 2008). 
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In addition, describing criteria for determining when an existing review of the same question requires 
updating should be considered. Updating a review will require fewer financial and human resources 
than conducting a new review. 
2. Summary of lessons learnt from the training sessions and the feedback of the participants 
via questionnaires 
The general consensus from views expressed by participants at the training workshops, was that 
systematic reviews are likely to have great benefit for one of the most important aspects of EFSA’s 
mission: transparency. This view was expressed in questionnaire feedback, with participants 
recognising the value of systematic review to transparently address specific questions within 
mandates. Respondents also noted that systematic reviews can enhance transparency internally (for 
example disagreements leading to lengthy discussions between experts) and externally (for example, 
when EFSA opinions are questioned). 
Another important and consistent message from the group discussion sections during the training 
workshops was that EFSA currently uses a great deal of experts’ time and that adding to the duties of 
panel and working group members could either be difficult to achieve or detract from the time spent 
on current EFSA activities. Concerns about time, resources and deadlines were mentioned in the 
majority of responses to the question “What are the main barriers to the adoption of systematic review 
methods within EFSA panels/units?” asked in the post-training questionnaire (79% of responses across 
the three training sessions). 
Therefore the Consortium proposes that the use of systematic reviews is considered thoughtfully, 
focusing on when the advantages of the systematic review method are likely to be most important. The 
primary advantages in this context are the use of explicit methods aimed at minimising bias and 
maximising transparency in order to produce the most reliable findings that can be used to inform 
decision making with the best body of evidence available at the time when the evaluation is 
performed. Nonetheless, there is a need to prioritise when systematic reviews, or components of 
systematic reviews, are undertaken. In post-training questionnaires, respondents recognised the 
importance of prioritisation, especially given the limited resources available to EFSA staff and 
experts. In line with the deliverables of this project, respondents also expressed a need for guidance in 
prioritisation and some respondents suggested prioritisation methods, for example a pre-scoping 
exercise, prior to accepting a mandate to help prioritise key questions and estimate the resources 
required to do a SR for them. 
During group discussion sessions, the participants noted that there are numerous long-term projects / 
issues that EFSA addresses over a multi-year time period. For these issues, there would be more time 
to identify components for which a systematic review would be beneficial and to prioritise the need for 
this type of input. It was also noted that some topic areas that may need to be addressed by EFSA are 
predictable and may be amenable to systematic review methods so as to have the information available 
to address issues as they arise. An example provided by participants was Salmonella. While a crisis 
situation might produce the need to provide input on an immediate topic for a specific species or 
production system, it would then be efficient, as time allows, to address the issue for other species or 
production systems. 
Regardless of timelines for systematic review, areas where the participants felt that systematic reviews 
should be a priority included controversial topics (which might be subject to greater scrutiny by 
external parties, including the public, and thereby would benefit from maximum transparency) or 
topics for which there was disagreement amongst experts in the content area. 
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It was noted that some areas addressed by EFSA have considerable potential impact and that these 
topics could be prioritised for systematic review. As described in the EFSA Guidance, the participants 
also noted that data inputs for influential parameters in risk assessments, when amenable to systematic 
review, should be prioritised. Regularly updating systematic reviews to address these parameters also 
might be an efficient means of determining when new evidence is likely to change a parameter 
estimate (thus necessitating an update of the RA) or to identify specific information gaps and research 
approaches needed to improve the RA accuracy. Some participants felt that topics amenable to 
systematic review that impacted multiple aspects of public health, animal health, animal welfare, or 
the environment should be prioritised over those that impacted only one of those areas. 
Participants also noted that the amount of literature available on a topic, and the timelines available to 
address a topic, should be incorporated into the prioritisation process. 
Participants noted that there were times when a systematic review approach might not be prioritised 
over other methods of collating available information. This included emergency situations where 
specific decisions must be made under very short timelines, such as during the immediate control 
activities associated with a point-source disease outbreak. In these situations, rapid reviews or other 
methods of decision-making may be more appropriate than full systematic reviews.  
Some participants also expressed concern about the potential impact of publication bias, noting that 
for some topics this might be a substantive issue that could negate the validity of a systematic review 
process. This is a valid point, however publication bias is relevant to all evidence synthesis methods 
not just systematic reviews. However, transparent and defensible alternatives were not apparent, other 
than attempting to identify un-published literature and to engage the private sector in data acquisition 
for systematic reviews when appropriate. 
The Consortium also noted that the overwhelming majority of training workshop participants were 
EFSA staff, although the courses were open to panel experts as well, with expenses paid. This balance 
in training workshops is not to EFSA’s benefit, and may impact adoption of the methodology. In some 
instances, opposition to adopted a new approach was encountered. This is an important problem to 
address because the consequences of a poor assessment are borne by EFSA, not the experts 
themselves. The Consortium applauds EFSA’s efforts to consider systematic reviews as a component 
of their scientific opinions and recommends that EFSA does not neglect new methodological 
developments in the field. In summary the participants of training sessions expressed the opinion that: 
 SR enhance transparency; 
 Problems with lack of time, resources and tight deadlines are challenges for implementing SR; 
 EFSA would need to prioritise topics for SR; 
 SR would be beneficial for controversial topics or topics where there is disagreement; 
 SR would be beneficial for topics where EFSA has considerable impact; 
 The availability of literature should be considered for prioritising; 
 There would be topics where a SR was not warranted or feasible (e.g. urgent situations). 
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3. Prioritisation approaches: A systematic approach to prioritising systematic reviews in food 
and feed safety 
Prioritising questions suitable for systematic review is critical for EFSA, as clearly there are many 
topics that could be amenable to systematic review within the scope of EFSA’s domains. However, 
EFSA needs methods of prioritising because resources are not available for all of the reviews that 
could potentially be conducted. The basic elements of a priority-setting process include: identifying 
potential topics; selecting the priority criteria; reducing the initial list of nominated topics to a smaller 
set to be pursued; and choosing the final priority topics (Eden et al., 2008). We discuss approaches to 
prioritisation by exploring briefly how other groups identify topics for systematic reviews and the 
prioritisation criteria they employ and then presenting a prioritisation approach for EFSA to consider.  
As has been the case with other agencies that face similar resource implications, a single checklist or 
decision tree approach that correctly identifies which reviews should be prioritised is elusive. This 
reality is a function of the fact that no prioritisation approach has been, or likely will ever be 
scientifically validated, because it is never possible to assess if the prioritisation method used led to 
the correct prioritisation, because non-prioritised reviews are not done. Therefore, no science based 
methods exist for assessing the validity of any prioritisation approach. Further, it is the firmly held 
opinion of the Consortium members that a single decision tree approach that is valid for every aspect 
of the EFSA mission cannot realistically be developed. Consistent with reports from prior groups, the 
Consortium did not identify a study that assessed prioritisation approaches and identified the best 
approach (Eden et al., 2008). 
Consequently, prioritisation approaches, both those used by other agencies and that proposed by the 
Consortium for EFSA, propose a transparent list of factors that have been consistently deemed 
important in the decision making process. Further, the Consortium incorporated the role that risk 
assessment plays in EFSA, which is unique compared to other agencies that have to date employed 
systematic reviews. Consequently this section is deliberately titled a “systematic” approach” rather 
than a “check list” approach or “ decision tree” approach for prioritising systematic reviews. Below we 
outline the approaches used by other agencies and propose a framework for EFSA.  
3.1. Approaches to identifying topics for review and prioritisation approaches used by other 
agencies that employ systematic reviews 
The basic elements of a priority setting process seem to be identifying potential topics, selecting the 
priority criteria, reducing the initial list of nominated topics to a smaller set of topics to be pursued, 
and choosing the final priority topics. 
No single method of identifying topics and setting priorities is obviously superior to others. This is 
because agencies that use systematic reviews have different roles in the decision- making process. 
Consequently, what is appropriate for one agency may not be appropriate for another one. One agency 
may focus on developing recommendations for clinicians, and another one on recommendations for 
national programmes and therefore their priorities would differ, along with the approaches used to 
identify those priorities. Thus, what is described hereafter is what happens in other organisations and 
the aim is not to refer to what happens in EFSA. 
Systematic reviews are so new in most areas of food and feed safety that there are, as yet, few 
agencies using systematic reviews to an extent that requires formal prioritisation procedures. 
Currently, in food and feed safety, systematic reviews have been commissioned by several 
government agencies such as the Public Health Agency of Canada, (Bucher et al., 2012a; Waddell et 
al., 2009; Wilhelm et al., 2011a; Wilhelm et al., 2009; Wilhelm et al., 2011b; Wilkins et al., 2010) 
United States Department of Agriculture (Denagamage et al., 2007; Guerin et al., 2010; O'Connor et 
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al.), UK Department for Environment, Food and Rural Affairs
6
 and the New Zealand Food Safety 
Authority (Jaros et al., 2008). Further, we are aware that systematic reviews have been funded by 
industry groups such as the American National Pork Board (O'Connor et al., 2012), American 
Soybean Foundation (O'connor et al., 2010a) and the American Meat Institute Foundation (O'Connor 
et al., 2012). However, none of these agencies or industry groups has provided the rationale for the 
topics chosen for review. Other reviews in food and feed safety have been conducted by research 
groups, without specific calls for review topics. The rationale or approach to prioritisation for these 
groups is similarly unclear. Probably, the individual investigators’ personal or group research interests 
drive the selection of review topics. To date, the only documented information available about 
identifying and prioritising topics for systematic review comes from human medicine.  
The Cochrane Collaboration is the best-known group that routinely supports, conducts and organises 
systematic reviews. The Cochrane Collaboration had no centralised process for setting priorities until 
2006. Before that time individual groups set their own priorities, which were likely to have been based 
on self interest: an approach described as “a curiosity-driven, bottom-up selection of topics” (US 
Cochrane Center Conference 10 -11 July 2008, 2009). Allowing investigators to decide about 
systematic review topics is an advantage for the larger scientific community, as the costs of reviews 
are likely to be lower if individual investigators are motivated to conduct reviews. This approach is not 
likely to be useful for agencies such as a health authority that needs to commission reviews to address 
predefined policy priorities.  
Most agencies in human health use a two-step process to identify potential topics for reviews. 1
st
 an 
eligibility step – where the agencies identify themes for reviews within their scope. The themes may 
be mandated by law depending upon the agency or identified by staff. After identifying themes for 
reviews that will be considered by the agency, the 2
nd
 step is a nomination step where those eligible to 
nominate submit review topics that are applicable to the eligible themes identified by the agency. This 
eligibility and nomination process can be seen as the 1
st
 step in prioritising. The theme identification 
can be thought of as a prioritisation step i.e., only topics of a certain nature will be considered. The 
nomination process could also be considered a minimum level for prioritisation, for example, if an 
agency identified the list of eligible topics and none are nominated, then a review of that topic will 
likely not be conducted. Examples of approaches to this aspect of prioritisation are contained in Table 
1. 
Resources describing how agencies established the eligibility or nomination process where not 
identified. Another approach used to identify topics is horizon scanning, which is described as 
monitoring of information sources for important topics. What constitutes good horizon scanning or if 
it is an effective approach to identifying topics for review is not apparent (Eden et al., 2008). There is 
some thought that this approach does lead to duplication of reviews (Eden et al., 2008). 
After topics have been identified using the eligibility and nomination process described above, 
agencies establish the priority criteria. The Consortium could identify no reports that described the 
process of how the priority criteria where identified. It was however possible to identify priority 
criteria used by other agencies. Examples are listed in Table 2. For some of the criteria definitions 
were not available from the relevant agencies, for other commonly accepted definitions are listed in 
Table 3.  
                                                     
6
 
http://randd.defra.gov.uk/Default.aspx?Menu=Menu&Module=More&Location=None&ProjectID=17402&Fro
mSearch=Y&Publisher=1&SearchText=systematic%20review&SortString=ProjectCode&SortOrder=Asc&Pagi
ng=10#Description 
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How the agencies use or used these priority criteria to narrow the list of topics and pick the final 
review varied between agencies but generally two approaches exist: 
 Quantitative methods that involve the collection of data that weight priorities were considered 
for some time however such weighting systems are rarely applied today. These systems 
assigned scores for each criterion to each topic, and the calculated priority scores for each 
topic to produce a ranked priority list. Such vote counting systems and weighting systems are 
rarely employed today because it is not possible to verify that the weights applied are correct 
and these can clearly be arbitrary (Eden et al., 2008). 
 An alternative was that a committee or advisory group reviewed the topic using the criteria 
and choose the topics. Some agencies used a formal group decision making method, such as 
the Delphi technique, to systematically develop the high-priority list (Eden et al., 2008). Other 
did not describe the approach. 
No agencies reported using a decision tree analysis approach to prioritising reviews. 
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Table 1: Methods used to identify topics for systematic reviews by selected health organizations 
(table originally published in National Academies of Science publication “Knowing what Works in 
Health Care” (Eden et al., 2008) 
Organization Methods Who Can 
Nominate 
Eligible Topics 
AHRQ (USA) Solicits topics 
annually through the 
Federal Register and 
accepts nominations 
on an ongoing basis 
Open to the 
public; AHRQ 
conducts 
systematic reviews 
for CMS, the 
USPSTF, and the 
NIH Consensus 
Development 
Conference 
Program 
Effectiveness of prevention, diagnosis, 
treatment, and management of common 
clinical and behavioural conditions; 
organization and financing; and research 
methods; topics addressed by the 
Effective Health Care Program must 
relate to 1 of 10 priority conditions 
established by the secretary of HHS
a
 
BCBSA TEC 
(USA) 
Solicits topics from 
within BCBSA and 
from its advisers 
TEC staff, medical 
directors of 
member plans, 
Medical Advisory 
Panel (external 
advisers), Medical 
Policy Panel, and 
pharmacy 
managers 
Effectiveness of surgical procedures, 
devices and implants, diagnostic 
imaging, laboratory tests, and targeted 
and specialty pharmaceuticals 
Cochrane 
Collaboration 
Varies across 51 
review groups 
Open to the 
public; reviews are 
author initiated or 
the topic is 
nominated and 
authors sought 
Broad range of clinical services and 
population-based health interventions 
DERP
b 
(USA) Program participants 
nominate topics 
State Medicaid 
programmes and 
other participating 
organizations 
Comparative effectiveness of drugs 
within classes of drugs 
MedCAC and 
CMS
b 
(USA) 
Internal decision MedCAC staff Devices, drugs, and procedures that are 
within the scope of Medicare coverage 
and subject to a national coverage 
decision 
NICE (UK) Internal decision by 
the department of 
health in England 
and Wales; NICE 
uses the National 
Horizon Scanning 
Centre to identify 
new and emerging 
technologies 
Individuals and 
groups 
Effectiveness of services that are being 
considered for coverage by the National 
Health Service, including drugs, devices, 
diagnostics, surgical procedures, and 
population-based health promotion 
NIH OMAR
b 
(USA) 
NIH institutes and 
centres and OMAR 
select topics on the 
basis of four criteria 
NIH institutes and 
centres, the U.S. 
Congress, other 
government health 
agencies, and the 
public 
Medical safety and efficacy; economic, 
sociological, legal, and ethical issues 
USPSTF
b 
(USA) Solicits topics Open to the public Clinical preventive services, including 
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Organization Methods Who Can 
Nominate 
Eligible Topics 
biennially through 
the Federal Register 
and appeals to 
stakeholders 
 
screening, counselling, and preventive 
medications for asymptomatic 
individuals 
NOTE: AHRQ = Agency for Healthcare Research and Quality; BCBSA = Blue Cross and Blue Shield Association; CMS 
= Centers for Medicare & Medicaid Services; DERP = Drug Effectiveness Review Project; HHS = U.S. Department 
of Health and Human Services; MedCAC = Medicare Evidence Development & Coverage Advisory Committee; 
NICE = National Institute for Health and Clinical Excellence; NIH OMAR = National Institutes of Health Office of 
Medical Applications of Research; TEC = Technology Evaluation Center; USPSTF = US Preventive Services Task 
Force. 
a The priority conditions are arthritis and non-traumatic joint disorders, cancer, chronic obstructive pulmonary disease and 
asthma, dementia, depression and other mood disorders, diabetes mellitus, ischemic heart disease, peptic ulcer 
disease and dyspepsia, pneumonia, and stroke and hypertension. 
b The reviews are conducted by an AHRQ EPC (Evidence-Based Practice Center). 
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Table 2: Factors considered when prioritising potential health topics identified for systematic 
review by selected health agencies  
Agency Factors considered 
Cochrane Collaboration for health 
promotion and public health research 
(Doyle et al., 2005) 
Burden of disease, magnitude of problem urgency 
Importance to developing countries 
Avoidance of duplication 
Opportunity for action 
US based Institute of Medicine (Eden 
et al., 2008) 
Potential to improve health 
Outcomes across the life span 
Reduce the burden of disease and health disparities 
Eliminate undesirable variation in practice 
AHRQ Effective Health Care 
Program (US Cochrane Center 
Conference 10 -11 July 2008, 2009) 
Appropriateness 
Importance 
Duplication 
Feasibility 
Potential impact 
Prevalence of a condition 
Burden of a condition 
Cost of care 
Disproportionate representation of the condition in the Medicare, 
Medicaid, S-CHIP populations 
UK National Health Service R&D 
and Department of Health 
Programmes (US Cochrane Center 
Conference 10 -11 July 2008, 2009) 
 
 
Horizon scanning (actual criteria not provided) 
Special mapping exercises in particular clinical areas to identify the 
most urgent need for guidance  
Individual patients and care givers  
Patient groups 
Professionals and professional groups 
National Health Service organizations  
Industry 
Drug Effectiveness Review Project 
(DERP). Oregon Health & Science 
University (US Cochrane Center 
Conference 10 -11 July 2008, 2009) 
Disease burden  
Alternative therapies  
Clinical impact  
Evidence review 
Marketing, and benefit/policy issues Budget/Economic impact 
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Table 3: Definitions of commonly used priority setting criteria (table originally published in 
National Academies of Science publication “Knowing what Works in Health Care” (Eden et al., 
2008) 
Criterion 
 
Definition 
Disease 
burden 
Extent of disability, morbidity, or mortality imposed by a condition, including effects 
on patients, families, communities, and society overall 
 
Controversy Controversy or uncertainty around the topic and supporting data 
 
Cost Economic cost associated with the condition, procedure, treatment, or technology 
related to the number of people needing care, unit cost of care, or indirect costs 
 
New evidence  New evidence with the potential to change conclusions from prior assessments 
 
Public or 
provider 
interest 
 
Consumers, patients, clinicians, payers, and others want an assessment to inform 
decision making 
 
Potential 
impact 
Potential to improve health outcomes (morbidity, mortality) and quality of life; 
improve decision making for patient or provider 
 
Sufficient 
evidence 
 
The available research literature provides adequate evidence to support an assessment 
 
Variation in 
care 
 
Potential to reduce unexplained variations in prevention, diagnosis, or treatment; the 
current use is outside the parameters of clinical evidence 
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3.2. Proposed framework for prioritising systematic reviews in EFSA 
The Consortium is aware that EFSA is not always in a position to decide on the form of a question or 
mandate. EFSA could consider conducting systematic reviews in two situations: 1) stand-alone review 
of an individual, focussed question and 2) a broad policy problem requires answers to various 
questions (e.g. a full risk assessment or any other analytical framework).  
3.2.1. Standalone systematic review of an individual, focused question 
EFSA may conduct systematic reviews related to a single topic that are conducted independent of any 
current risk assessment model and are based on a long-standing or anticipated or new need. In this 
situation the Consortium envisions the following scenario. When these reviews are self-tasked by 
EFSA, they lend themselves to the processes for identifying relevant topics used by health agencies 
(such as those outlined in Table 1 above), although some adaptations to the EFSA regulatory 
framework may be necessary.  
Note that the Consortium anticipates that such reviews would never be the subject of rapid reviews 
and would be instead be full systematic reviews with all the steps that characterise a high quality 
review because they represent commitments made by EFSA. This practice is followed by other 
agencies. Such reviews would also need to be updated regularly and a time schedule and resources to 
rapidly update such reviews should be established. 
Recall the basic elements of a priority setting process seem to be identifying potential topics, selecting 
the priority criteria, reducing the initial list of nominated topics to a smaller set of topics to be pursued, 
and choosing the final priority topics.  
EFSA must first identify the topic. What is eligible is already clear from EFSA legislative and 
regulatory authority. Although EFSA may find it useful to narrow the scope by limiting eligible topics 
to those topics viewed as so important to have as a readily available up-to-date evidence review. A 
justification for the narrower eligibility criteria is that this could be viewed as long-term investments 
in staying abreast of current fast-moving evidence and being prepared to offer an evidence-based 
review or opinion. Although eligibility of topics is likely set by those with decision-making authority 
within EFSA, EFSA still does need a process for accepting nominations. Based on comments from 
EFSA staff, this would not involve stakeholder input; therefore the Consortium assumes that the only 
source of a potential list of topics is EFSA staff. Therefore, EFSA must establish a mechanism to 
solicit review topics from EFSA scientific officers for self-tasked reviews. Once the topics have been 
identified or nominated, the reduction of the list to a smaller list and a final topic should be similar to 
that used by other organisations as described in above.  
The Consortium considers that for prioritising the nominate review topics the criteria in Table 4 could 
be considered. The methods of applying these criteria in a systematic fashion are outlined in Figure 1. 
The linkages between Table 4 criteria and the questions in Figure 1 are provided in Table 4. Those in 
EFSA charged with making the decision should ask the Figure 1 questions for each review topic and 
select the systematic reviews topic with the highest priority. The final decision should be articulated 
within this frame work. For example a review may be chosen because, based on the opinion of the  
those with decision-making authority within EFSA, one review is more important because of criteria it 
meets are more important compared to the other review topic. 
The Consortium discourages EFSA from employing vote counting system to prioritise reviews (i.e., 
the review with the most yes responses is chosen). The Consortium also does not imply that the 
questions are hierarchical, i.e. the review that answers the 1
st
 yes should be prioritised. The rationale 
for discouraging such approaches is as followed. For a hierarchical system to be valid it would be 
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necessary to ensure that in all situations the 1
st
 yes is always the most important. This is not possible. 
The vote counting approaches require validation that the combined weight of "yes” responses to the 
lower questions equal or outweigh the importance of one of the higher questions. Such validation is 
not possible. Further such quantitative approaches are complicated by the strength with which it is 
possible to say "yes" to any particular question may vary (for example, the amount of expert 
disagreement may be high, medium or low). 
Table 4: Criteria proposed by the Consortium for EFSA to consider when prioritising systematic 
review topics that have been identified as candidates for stand-alone systemic reviews and are not 
currently the subject of a risk assessment model 
Criterion Rationale  Figure 1 question 
Q1. Relative importance of the 
review topic  
A review topic may be prioritised according to the 
potential consequences of e.g. an intervention or 
exposure relative to other scenarios. For example: 
 Human health takes priority over other 
species or over environmental impacts; 
 Within humans, high morbidity, long-term 
and large-scale effects take priority over 
low morbidity, short-term and local-
population effects. 
Q1. Is the question of 
high importance to 
animal/human or 
plant health? 
 
Q2. High consequence of action 
or exposure 
In the absence of comparison scenarios, a topic 
may be immediately identifiable as high priority if 
it is likely to have high-impact and/or high-profile 
consequences. An example is potential threats to 
pollinators. 
Q2. Will there be an 
important impact of 
any action/exposure? 
 
Q3. Disagreement among 
experts 
Disagreement may reflect selective utilisation of 
the evidence by experts, or real uncertainty in 
what the primary evidence shows. Disagreements 
can be detrimental to scientific progress. 
Independent systematic reviews provide the 
transparency of evidence synthesis to clarify the 
root of disagreements and nature of the primary 
evidence. 
Q3. Is there expert 
disagreement on the 
review question? 
 
Q4. High public scrutiny Areas of risk assessment that are regularly in the 
public eye require best practice in transparent 
evidence synthesis to be followed to minimise the 
risk of misconceptions and misunderstandings. 
Here the transparency of the process is the most 
important benefit for EFSA. 
Q4. Is the review 
question the subject 
of high public 
awareness? 
 
Q5. Potential to intervene A systematic review is likely to be more 
immediately productive if addressing topics that 
are likely to result in changes to practice or policy 
without extensive further research and 
development being required. 
Q5. Are the review 
results likely to be 
immediately 
implementable? 
 
Q6. “Reach” of a review A review topic likely to influence policy or 
practice at a large scale may take priority over a 
topic that affects a relatively small subset of 
populations, scenarios or countries. 
Q6. Is the review 
likely to have large 
(international) policy 
practice implications? 
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Q7. Extent of evidence EFSA may prioritise reviews to summarise 
extensive evidence on a topic if no alternative 
rigorous synthesis exists. 
Q7. Will the review 
summarise a large 
volume of research 
evidence not already 
reviewed? 
Q8. Real or perceived 
knowledge gap 
It may be useful to expose a knowledge gap 
through systematic review and highlight need for 
primary research. This may be particularly 
necessary when community wrongly believes that 
evidence exists. 
Q8. Will the review 
expose and confirm 
an evidence gap and 
inform the 
development of 
primary research? 
An example will be used to illustrate the process the Consortium proposes that EFSA employ. Let us 
imagine that EFSA staff have been asked to nominate a topic for self-tasked reviews by a process 
established by EFSA. Only two topics are nominated: a request for review of the impact of probiotics 
in human health and a request for a review of the sensitivity and specificity of pain indicators in non-
religious slaughter of animals. The people charged with making the decision about which review to 
prioritise must assess each topic based on the criteria in Table 4. Let us imagine that the decision 
making group within EFSA considers that for the 1
st
 review topic, the response is “yes” for Q1, Q3, 
and Q7, and for the 2
nd
 review topic, the response is “yes” for Q1, Q2 and Q8 (note these are simple 
examples and do not reflect real responses or the opinion of the Consortium or EFSA on these topics). 
If the decision making group decides to conduct the 1
st
 review, it should record the differences in 
responses and indicate that for this comparison, positive responses to Q3 and Q7 were considered a 
better rationale for directing resources to a review than positive responses for Q2 and Q8. In different 
situations a differ conclusion may be reached, however using this approach EFSA has 1) documented 
the questions considered when prioritising, 2) transparently reported the final rationale and 3) not rely 
on an unjustified weighting or hierarchical scheme. 
The prioritisation framework illustrated in Figure 1 is flexible: if more systematic review questions are 
initially prioritised than can be conducted with the available resources, then the prioritisation process 
could be rerun iteratively using stricter decision criteria. To ensure transparency and repeatability in 
the documentation and reporting of the responses to questions in Figure 1, a template based on the 
flow chart illustrated in Figure 1 may be helpful for recording the decisions made. 
When and if it occurs that reviews of individual, focussed questions are commissioned by external 
requestors (e.g. the European Commission), the topic of the review will of course be chosen by the 
requestor and the decision about prioritisation will not be relevant. 
  
 Implementation of systematic reviews 
 
Supporting publications 2012: EN-367 21 
The present document has been produced and adopted by the bodies identified above as author(s). This task has been carried out exclusively 
by the author(s) in the context of a contract between the European Food Safety Authority and the author(s), awarded following a tender 
procedure. The present document is published complying with the transparency principle to which the Authority is subject. It may not be 
considered as an output adopted by the Authority. The European food Safety Authority reserves its rights, view and position as regards the 
issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Questions related to the prioritisation criteria proposed for systematic review within EFSA 
3.2.2. Various reviews to answer a broad policy problem 
Alternatively, EFSA may conduct one or more systematic reviews to address a broad policy problem 
(i.e. full risk assessment, sets of questions or any other analytical framework that requires more than 
one question to be answered for being fully addressed). For example, in a recent mandate about meat 
inspection systems, the impact of changes in the meat inspection system was modelled as part of risk 
Q1. Is the question of high importance to animal/human 
or plant health? 
Consider 
prioritising for 
systematic review 
Identify review 
question 
Yes 
No 
Q2. Will there be an important impact of any 
action/exposure? 
No 
No 
Q3. Is there expert disagreement on the review question? 
Yes 
Q4. Is the review question the subject of high public 
awareness? 
Yes 
Q5. Are the review results likely to be immediately 
implementable? 
Yes 
Q6. Is the review likely to have large (international) 
policy practice implications?
 
Yes 
Yes 
No 
 
Q7. Will the review summarise a large volume of 
research evidence not already reviewed? 
Yes 
Q8. Will the review expose and confirm an evidence gap 
and inform the development of primary research? 
Yes 
No 
Review should not be prioritised at this point in time. 
No 
No 
No 
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assessment
7
. To enhance the validity of the risk assessment model, a systematic review of some 
parameters could be helpful, despite the fact that these topics would not have previously been high 
priorities outside of a mandate. 
Performing a systematic review of all questions included in a broad policy problem is unlikely to be 
feasible and thus prioritising questions for systematic review is of crucial importance when dealing 
with broad policy problems. Here the process proposed by the Consortium is only minimally different. 
Recall the steps to prioritise review questions: the basic elements of a priority setting process seem to 
be identifying potential topics, selecting the priority criteria, reducing the initial list of nominated 
topics to a smaller set of topics to be pursued, and choosing the final priority topics. The Consortium 
anticipates that one difference that will occur will be in the process used to identify the topics. Instead 
of seeking nominations as used by other agencies and proposed for stand-alone reviews, when a risk 
assessment model is available – this should be used to identify the topic. This model may be 
conceptual or mathematical however either can be used to create the list of topics that must be topics 
for review. 
The next step is the prioritisation criteria. Here the Consortium proposes using criteria in Table 4 
combined with the criteria in Table 5. The process of combining these is illustrated in Figure 2. 
The prioritisation process for systematic review questions arising from a broad policy problem is 
summarised in a flow chart in Figure 2. As with the prioritisation of standalone review questions 
described above, the prioritisation process for questions arising from a broad policy problem may be 
flexible to ensure that the number of review questions prioritised is appropriate for the available 
resources. The flow chart may also be adapted as a reporting template to ensure transparency in the 
documentation and reporting of the decisions made concerning the prioritisation of review questions. 
Table 5: Additional criteria for prioritising systematic reviews when a risk assessment model is 
available (Van der Sluijs et al, 2005) 
Criteria Question in process 
Anticipated local effect in the model  Will the evidence from the review inform an element of 
high importance in the risk assessment model? 
Anticipated structural effect in the model Will the evidence generated by the review potentially 
alter the structure of the model in the risk assessment? 
Impact of parameter in model (sensitivity 
analysis) 
Is the review evidence likely to input to sensitivity 
analysis? 
 
As an example of how to apply the prioritisation approach proposed by the Consortium in the situation 
when a conceptual but not mathematical model is available, we can use an animal health import risk 
assessment. For such a topic it is easy to imagine there being a conceptual model which would identify 
all the possible topics for review, i.e., the parameters that will be included in the model.  
The conceptual model contains several parameters but we focus on just two - the prevalence of the 
disease in the country and the sensitivity and specificity of the diagnostic test used to detect the 
disease. In this situation, the decision maker(s) could use the flow chart in Figure 2 to narrow down 
                                                     
7 EFSA Panels on Biological Hazards (BIOHAZ), on Contaminants in the Food Chain (CONTAM), and on  
Animal Health and Welfare (AHAW); Scientific Opinion on the public health hazards to be covered by inspection of meat 
(poultry). EFSA Journal 2012;10(6):2741. [179 pp.] doi:10.2903/j.efsa.2012.2741. Available online: 
www.efsa.europa.eu/efsajournal 
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and prioritise the systematic review topics in a transparent documentable approach. Beginning with an 
example that only seeks to prioritise either the review of the prevalence in the country of origin or the 
characteristics of the diagnostic tests. If we imagine that based on the flow chart, the decisions makers 
answer “yes” for Q1 and Q2 in Figure 2, Q3 will be “no” as a mathematical model does not yet exist. 
They would then move to the criteria in Table 4 and answer those questions. Perhaps, all are “no” 
except a “yes” response for Q3 in Table 4 for both topics but only for the diagnostic tests assay is there 
a “yes” response to Q7 in Table 4, i.e., the amount of information available. That is, it is clear that for 
the prevalence estimate question there is little or no published data are available but for the question 
about the diagnostic test method numerous studies are expected. In this situation, the Consortium 
would expect that the decision maker would prefer to conduct the review on the diagnostic test.  
Although this example could be interpreted as a “vote” counting approach, the Consortium does not 
recommend such an approach to defending prioritisation decisions because as illustrated in a prior 
example, such an approach is not always a workable option. The rationale for the recommendation in 
this example should be that, all other things being equal, the review the diagnostic assay was selected 
because the topic had the advantage of having a stronger body of data for a review. The incorrect 
rationale for the recommendation would that that the prevalence topic received 3 “yes” responses and 
the diagnostic test received 4 “ yes” responses. 
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Figure 2: Prioritising review questions from a broad policy problem 
Yes 
Q2. Will the evidence from the review inform an element 
of high importance in the risk assessment model? 
Consider 
prioritising for 
systematic review 
Q1.Does the question 
inform a risk 
assessment? 
Yes 
No 
Q3. Will the evidence generated by the review potentially 
alter the structure of the model in the risk assessment? 
No 
Q4. Is the review evidence likely to input to sensitivity 
analysis?  
Yes 
The criteria in Figure 1 and Table 4 
Yes 
Review should not be prioritised at this point in time 
 
Yes 
No Consider the priority of the question according to the 
criteria for standalone systematic review questions in 
Figure 1 and Table 4 
No 
No 
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4. Feasibility and Resource Impact Assessment: An approach to adapting the systematic 
review methodology in cases of limited resources 
Although topics may be prioritised, it is also important that EFSA addresses resource factors that limit 
the feasibility of conducting any systematic review. The availability of resources should be used to 
judge whether a systematic review will assist with estimating parameters or answering the questions. 
These resources are: time, staff (availability and expertise); primary evidence; and technical resources. 
These four resources are not independent (e.g. staff availability may influence the time required for a 
systematic review). Key technical resources required for a systematic review include bibliographic 
databases, literature management software and statistical analytical tools. For the purposes of this 
framework the Consortium assumes that the availability of technical resources within EFSA is not a 
limiting factor. Therefore we focus on the three remaining resources which will be required: time; staff 
availability and expertise and primary evidence.  
4.1. Time issues: short deadlines and the utility of rapid reviews 
According to the Cochrane Collaboration Handbook (2011) a systematic review “attempts to collate 
all empirical evidence that fits pre-specified eligibility criteria in order to answer a specific research 
question. It uses explicit, systematic methods that are selected with a view to minimizing bias, thus 
providing more reliable findings from which conclusions can be drawn and decisions made”. 
Systematic reviews take time and resources if they are to be properly executed. However, EFSA and 
other government agencies frequently have to respond to policy makers’ requests for information in a 
time frame shorter than necessary to complete a full systematic review. In human medicine, systematic 
review tools to respond to these requests are referred to as rapid reviews. In other fields the terms 
“rapid evidence reviews” and “pilot reviews” have been used. 
For EFSA, rapid reviews may be a useful tool but they should not be viewed as a substitute for a full 
systematic review. Rapid reviews and systematic reviews should be clearly differentiated. Criteria 
about what constitutes a rapid review and what shortcuts are taken to ensure that the review is rapid 
are not standardised. In a study of institutions using rapid reviews to support policy making, a major 
difference between systematic reviews and rapid reviews was that fewer sources were used when 
searching the literature to identify relevant studies (Watt et al., 2008a). Searching the grey literature 
and hand searching were the most commonly omitted steps in rapid reviews compared to systematic 
reviews. 
Rapid reviews also tend to be more restrictive in terms of the type of primary study that would be 
considered relevant. For example, in a study of 36 rapid reviews, none excluded systematic reviews; 
6% excluded randomized controlled trials (RCTs); 17% excluded nonrandomized controlled trials; and 
83% excluded case series (Watt et al., 2008a). In contrast, no full systematic review excluded RCTs, 
only 8% excluded nonrandomized studies, and 31% excluded case series (Watt et al., 2008a). With 
respect to the outcomes considered, rapid reviews are more likely to restrict the number of outcomes 
considered, and in health care, the outcomes omitted by rapid reviews have tended to be social and 
economic rather than clinical outcomes (Watt et al., 2008a).  
Rapid reviews are also less likely to include external reviewers or larger stakeholder groups in the 
review process and this may be a disadvantage. If EFSA would encourage the use of rapid review too 
frequently, or working groups incorrectly developed the idea that rapid reviews are the solution to all 
review questions, the in-house workload for EFSA staff (with less involvement of external experts), 
who would be expected to conduct the rapid reviews, may actually increase.  
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The implications of these differences between rapid reviews and systematic reviews are important for 
EFSA. The project Consortium proposes that when developing an approach to rapid reviews, EFSA 
should take the steps described below. 
4.1.1. Describe the minimum number of databases that should be evaluated 
This number may differ between topics, but a minimum of two at least allows some consideration of 
complementarity and redundancy. The Consortium believes that for animal health outcomes, a 
minimum requirement for a database which has to be searched might be CAB Abstracts, which has a 
far broader scope for animal health and welfare than, for example, MEDLINE. For human nutrition, 
MEDLINE, for biological hazards, Food Safety and Technology Abstracts may be the minimum 
requirement. As the number of reviews conducted in EFSA increases, it would be helpful to conduct 
retrospective analyses and determine which of the readily available databases most effectively 
captured the citations that ultimately were included in reviews. This relative recall analysis is a 
standard approach used in systematic review information retrieval research. Such information could 
provide an empirical basis to recommend the best databases when conducting rapid reviews
8
. 
4.1.2. Ensure that the most critical outcome is identified before the review is 
conducted 
Many interventions and exposures lead to multiple outcomes, all of which may be of interest. 
However, at the beginning of a rapid review, content experts should quickly identify all possible 
outcomes and grade these as critical, important or non-important. For example, if EFSA was asked to 
provide a rapid review of the consequences of exposure to a toxin such as melamine in calf feed, 
numerous outcomes of interest could be identified in humans and animals. Within these populations, 
outcomes are likely to differ by severity. For example, the contamination of meat products may lead to 
kidney failure or behavioural changes in children. It is likely to be more important in the short term to 
provide information about the impact on kidney failure than behaviour changes, and both outcomes 
are more important than any outcomes that occur in calves. Rapid review searches could, therefore, be 
limited to one or two critical outcomes. 
4.1.3. Discuss and clarify, prior to conducting a rapid review, what the limitations of 
the evidence base will be 
In some areas, it is possible to limit a rapid review to a review of existing systematic reviews. For 
example, if EFSA was required to provide rapid opinions about the effects of probiotics on human 
health, numerous systematic reviews are available on this topic (Abad and Safdar, 2009; Boyle et al., 
2009; Braegger et al., 2011; Brenner et al., 2009; Chmielewska and Szajewska, 2010; Hempel et al., 
2012; Holte et al., 2012; Hoveyda et al., 2009; Jonkers et al., 2012; Mihatsch et al., 2012; Moayyedi et 
al., 2010; Salari et al., 2012; Vouloumanou et al., 2009; Whelan, 2011; Whelan and Myers, 2010). 
Similarly, a rapid review of pre-harvest interventions of Salmonella in pork could use previously 
published reviews updated with additional limited searches. In other situations, EFSA staff and experts 
would need to think very critically about the evidence base to be considered in the review, because the 
larger the evidence base, the longer the time required for a review. A simple way to achieve a 
reduction in time cost is to consider including more methodological or study design criteria in the 
eligibility criteria, which leads to a reduction in the information that needs to be extracted. 
                                                     
8
 In this respect, EFSA editors of the document wanted it noted that EFSA is currently undertaking a project to 
produce an Inventory of reliable information sources relevant to the various EFSA areas and to define a method 
for defining the best combinations of information sources that would ensure that relevant information is retrieved 
for every new review question started (CFT/EFSA/SAS/2011/03, “Inventory of sources of scientific evidence 
relevant to EFSA risk assessments and information sessions on literature searching techniques”). 
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Table 6: An example of the general comparison of rapid review versus systematic review 
approaches conducted by Knowledge to Action in Canada (Khangura et al., 2012) 
 Rapid review Systematic review 
Timeframe ≤ 5 weeks 6 months to 2 years 
 
Question Question specified a priori (may include 
broad PICOS) 
Often a focused clinical question 
(focused PICOS) 
Sources and searches Sources may be limited but 
sources/strategies made explicit 
Comprehensive sources searched 
and explicit strategies 
 
Selection Criterion-based, uniformly applied Criterion-based 
Appraisal Rigorous; critical appraisal (SRs only) Rigorous; critical appraisal 
 
Synthesis Descriptive summary/categorization of the 
data 
Qualitative summary +/- meta-
analysis 
 
Inferences Limited/cautious interpretation of the 
findings 
Evidence-based 
 
 
Rapid reviews currently attract a lot of interest in health research (Khangura et al., 2012; Watt et al., 
2008a, b), but experience so far mainly comes from individual groups and institutions. This area is 
likely to develop further in the near future and it is likely that more precise recommendations will be 
available on the utility, preparation and conduct of rapid reviews in 1-2 years’ time. If EFSA is 
interested in this approach the Consortium suggests they conduct a trial to compare the impacts and 
outcomes of both rapid and full systematic reviews. 
4.2. Staff issues: availability and expertise 
This element of resource has three components: the staff available for the review; the number of 
person days EFSA experts or staff can contribute to a review; and the availability among staff of 
expert skills. For a systematic review, a minimum of two persons are required for the majority of SR 
steps. For simplicity, the Consortium assumes that staff expertise covers technical resources (e.g. 
information specialism implies access to bibliographic databases and statistical expertise implies 
access to analytical software) and that panel and working group experts cover the domain expertise in 
the field of the systematic review. The calendar time required to complete a review from the stage of 
question setting varies greatly according to the question and the volume and quality of evidence. 
Based on reviews conducted by the Consortium members, the average may be more than one year but 
the range can be from six months to two years (Khangura et al., 2012). 
4.2.1.  Availability of staff or staff days available for a review 
If a review is needed and EFSA does not have the staff or staff days to devote to a review several 
options exist. The first option is to not conduct a review. The 2
nd
 option is to extend the calendar time 
available for the review- this option seems unlikely to be useful for reviews commissioned by an 
external requestor. For self-tasked reviews, the same options exist however it seems more likely that it 
will be possible to extend the calendar time available for such reviews which would enable greater 
involvement of the EFSA staff and working group experts in the review process. Particularly, efforts 
should be made to ensure that, for high priority reviews, panel and working group members and EFSA 
staff are involved in protocol development. The third option is that an outside contractor can be 
commissioned to complete data screening extraction, analysis and interpretation steps. The outside 
contractor may interact with EFSA staff and panels for the interpretation process, provided such 
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consultation does not interfere with the independence and integrity of the review. An additional option 
would to be modify the output from a full systematic review to a rapid review (or at least less 
“resource intensive”) and take measures such as limiting the number of reviewers to reduce the 
workload e.g. only one person selecting the studies for inclusions and maybe another just checking a 
subset of records to see if ok; or only one person to do the data extraction. The reduction in workload 
will also correspond with losing many of the benefits of conducting a review such as a transparent 
defensible process. 
4.2.2. Availability among staff or experts of expert skills 
In the short term there are few solutions to this problem, although medium and long term solutions are 
available. The project Consortium feels that, given the diversity of expertise in EFSA staff and 
working group members, it would be unusual that the deficit in expertise would be a lack of subject - 
specific content expertise. More likely, staff or working group members who are familiar with 
systematic review methodology would be few. If the EFSA staff or experts available are not aware of 
the systematic review methodology and cannot complete a review, an alternative approach to 
synthesising the research must be sought. The medium term solution would be to employ outside 
experts in systematic reviews to guide the review process. We envision two main situations where this 
it may be advisable to employee outside expertise. 
First, an outside expert may be needed where questions are more difficult to answer in areas where the 
systematic review methodology is less well-developed and sources of bias are less well-defined, these 
cases require considerable methodological expertise. An example would be reviews of diagnostic test 
accuracy. In this situation, it would be desirable to identify an individual who is familiar with 
diagnostic test accuracy review methods. If that individual has no familiarity with feed and food 
safety, either an EFSA staff member, or a second consultant or a workgroup member, familiar with 
systematic reviews, should be included in the review team. 
The second situation where an outside expert may be needed will occur when a panel that does not 
normally employ systematic reviews tries this for the first time. In this situation, a methodology expert 
familiar with systematic reviews and food and feed safety, but not necessarily the content domain, 
should be involved to facilitate the process. It seems that a recent tender process set out by EFSA may 
be able to address this medium term solution in an efficient manner.  
The long term solution is to increase the training in systematic review and methodology expertise, a 
step that EFSA has already initiated. 
4.3. Primary evidence: availability and scoping 
In many topics, it is possible that the evidence base is limited or non-existent. The Consortium 
believes this is likely to be established in two ways. First, and most likely, the EFSA staff or working 
group experts in the area will be aware that the amount of evidence for the question of interest is very 
small. Alternatively, a scoping exercise may have identified a lack of evidence. In these situations, a 
systematic review is unlikely to be needed (unless there is some disagreement about the amount of 
evidence). However, for the purposes of transparency, the Consortium recommends EFSA to conduct 
an evidence scoping project to document the lack of evidence. In particular, when experts are 
consulted and they advise that little or no evidence is available, a scoping exercise should still be 
carried out and the results documented. As each review should begin with a scoping exercise, the 
Consortium suggests that each EFSA review team has a point at which the decision to proceed with 
reviewing the literature or use an alternative approach should be built into the EFSA workflow, 
therefore documenting this process should not be a major burden. In certain circumstances it may be 
decided that a systematic review is necessary to confirm that the evidence base is inadequate to 
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support current decision-making needs. This may be beneficial in terms of prioritising an area for 
primary research. 
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5. Discussion on any actual and potential barriers to, and facilitators of the implementation of 
systematic reviews with the EFSA risk assessment framework 
As mentioned in previous sections, time is a major barrier to the conduct of systematic reviews within 
EFSA’s work process. The element of time includes both the allocation of personnel to conduct the 
review, and the often short timelines available to provide an opinion or prepare a risk assessment. It is 
recognised that timelines for some issues are by necessity short (e.g., input related to outbreaks or 
emerging crises). However, in other instances, an increased understanding of the time commitment 
required relative to the benefits may lead to a better understanding by those submitting the mandates 
of the time required to incorporate systematic reviews. It should be remembered that rapid reviews are 
not a replacement for systematic reviews, and employing rapid reviews simply replaces one set of 
issues with another. Instead the use of rapid reviews, substitutes one set of issues (time and resource) 
for another (less robust, transparent and comprehensive processes for incorporating scientific evidence 
into EFSA decisions). EFSA will need to determine which set of issues takes precedence.  
Another potential barrier may be lack of familiarity of all relevant persons with the process (including 
timelines) and the benefits of a systematic review. While EFSA has conducted several training 
sessions on systematic reviews for staff and experts, the Consortium believes that there are individuals 
within both of these groups that do not understand, or perhaps do not appreciate the process. In 
addition, there may be a need to inform the individuals who create the mandates provided to EFSA 
about the process and benefits of systematic reviews. Ultimately, this may help to alleviate the issue of 
unrealistic timelines and facilitate incorporating reviews into the EFSA process.  
As outlined in the EFSA Guidance, the primary advantage of the systematic review is the transparency 
and robustness that it provides to the evidence synthesis and communication process. This is 
particularly important when high- consequence problems or controversial issues are addressed by 
EFSA. It also is advantageous in situations where public scrutiny is high or where there is 
disagreement amongst experts. The transparency inherent in the systematic review process will aid 
EFSA in defending positions to a concerned public and to those whose personal opinions may not be 
consistent with the scientific evidence. Transparency is also important when risk assessment is used 
for regulatory purposes. The incorporation of systematic reviews may help in cases where the 
regulatory decision is challenged. When considering the prioritisation of questions for systematic 
review in the short term, it may be worth identifying issues which facilitate their acceptance as a 
valuable tool in decision-making. 
6. Conclusions 
Risk assessment is an approach to understand hazards and impacts of hazards in a system. Risk 
assessment in food and feed safety focuses on the food production system, which is incredibly 
complex. In food and feed safety, risk assessment is the nationally and internationally recognised 
approach to informing policy-making. Health management, health technology assessments (HTA) and 
cost effectiveness assessments (CEA) seek to provide similar support for decision making, by 
including not just efficacy, but also factors associated with the entire health care system (including 
comparative treatments and costs). In decision making concerning human health issues, therefore, 
systematic reviews form just one component of the decision making process. 
EFSA and all its Panels should view systematic reviews in the same manner, as a method that 
enhances and adds value to risk assessments and recognises that the methodology offers a number of 
strategic advantages in terms of transparency and evidence-informed decision making. EFSA has 
acknowledged that systematic review is expensive and time-consuming and a decision-making 
framework is needed to identify when to use it and how to prioritise question when resources are 
limited. With this in mind, EFSA has outlined the importance of considering when the benefits of 
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systematic reviews are going to be the highest. Decision making can be complex and one way of 
describing the components that inform decision making is to describe the 1) evidence base 2) values 
and preferences 3) costs and benefits and 4) balance of benefits and harms.  
In summary, the use of systematic review methodology in food and feed safety is still in its infancy.  
Based on the expertise of its members and the experience developed during the training sessions 
delivered to EFSA experts and staff, the Consortium defined an approach to prioritising questions for 
systematic reviews. The Consortium also outlined some potential barriers to use of systematic review, 
including time, expertise and available evidence and discussed potential solutions, including use of 
rapid reviews and, as already acknowledged by EFSA, continuation of training opportunities. 
Appropriate commissioning of systematic review expertise is regarded as an important step in 
establishing the role of the methodology in EFSA risk assessments.  
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